Vraylar (Cariprazine) - Newest and Best Antipsychotic?
What is Vraylar (Cariprazine)?

What is Vraylar (Cariprazine)?
Vraylar is the newest atypical antipsychotic on the market. It has several indicated uses including Bipolar Disorder, Schizophrenia, and then augmentation therapy for Major Depressive Disorder. Vraylar is supposed to be superior to other atypical antipsychotics by having less severe side effects. Vraylar is said to have less impact on weight gain compared to other antipsychotics. Unlike most antipsychotics, it is approved for
History of Vraylar
Vraylar was developed by Geodon Richter and was approved for use in the United States in September 2015. It is available as a generic medication.
Mechanism of Action of Vraylar
Vraylar acts similarly to other atypical antipsychotics such as aripiprazole and brexpiprazole. It is a partial agonist (or activator) of the D2 receptor. It also has agonist (or activating) actions on the D3 and serotonin 5-HT1A receptors as well as antagonist (or blocking) activity at serotonin 5-HT2A receptors. Since it is only a partial agonist at D2 and D3 this can account for less weight gain on Vraylar.
Side Effects/ Adverse reactions / Contradictions
Side effects include but may not be limited to, fatigue, pyrexia, extrapyramidal symptoms, akathisia, headache, somnolence, dizziness, agitation, insomnia, restlessness, anxiety, dystonia, parkinsonism, tachycardia, HTN, blurred vision, nasopharyngitis, toothache, oropharyngeal pain, abdominal pain, constipation, diarrhea, dyspepsia, nausea, vomiting, dry mouth, weight gain, decreased appetite, arthralgia, back pain, extremity pain, muscle stiffness, cough, rash.
Extrapyramidal Symptoms (EPS) and Tardive Dyskinesia (TD)
With all antipsychotic medications there is potential for developing Extrapyramidal Symptoms (EPS) and Tardive Dyskinesia (TD). EPS in involuntary, uncontrollable movements. These movements are usually lip-smacking or pill-rolling or uncontrollable twitches. EPS can be treated with the medication Cogentin (Benztropine). However, EPS symptoms can become permanent. This is called Tardive Dyskinesia. This is why it is very important that you report to your prescriber immediately if you develop these symptoms. They can be treated but you want to catch them before they become permanent.
Black Box Warnings
Can increase the chance of death in patients with dementia related psychosis. Cariprazine can increase suicidal ideation and increase the risk of suicide. Report any new or worsening depression to the prescriber immediately.
Withdrawal or Discontinuation Syndrome
Like other antipsychotics, do not stop taking Vraylar suddenly as this can result in discontinuation syndrome. Symptoms of withdrawal from an antipsychotic include agitation, anxiety, worsened depression, headache, dizziness, muscle aches/pain, diarrhea and nausea.
Positives or Pros of Vraylar
Vraylar is approved for use in Major Depressive Disorder unlike most atypical antipsychotics. Vraylar has a decreased potential for weight gain compared to other antipsychotic medications. It is available as a generic and should be covered by most insurance companies. Vraylar may be a great option, especially for those who are looking for an add-on treatment for depression.
Negatives or Cons of Vraylar
Vraylar is still an antipsychotic medication and has a plethora of side effects. You must be very careful with the black box warnings on this medication. You must watch for EPS and TD as well as increased suicidal ideation.
The Anxious Resistance Take
Vraylar shows a lot of potential with its lessened weight gain. Weight gain is one of the biggest reasons that people stop antipsychotic treatment. Especially in those taking antipsychotics for depression. Weight gain from antipsychotics is often not dose dependent. This means that regardless of what dose of the medication you are on, you’ll gain weight. Vraylar works for its intended indications of schizophrenia, bipolar and depression. Overall, Vraylar may be a great option if you are looking for an antipsychotic with less weight gain and less sedation.
Words worth knowing
Insomnia
A sleep disorder involving persistent difficulty falling asleep, staying asleep, or getting restorative sleep.
Black box warning
The FDA’s most prominent medication warning, used when a medicine carries a serious or potentially life-threatening risk.
